Table of Contents Author Guidelines Submit a Manuscript
International Journal of Pediatrics
Volume 2011, Article ID 951616, 7 pages
http://dx.doi.org/10.1155/2011/951616
Review Article

Drug Testing for Newborn Exposure to Illicit Substances in Pregnancy: Pitfalls and Pearls

1Section for Children at Risk, Department of Pediatrics, University of Arkansas for Medical Sciences, 1 Children's Way, Slot 512-24A, Little Rock, AR 72202, USA
2Section for Pharmacology and Toxicology, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA
3Section for Neonatology, Department of Pediatrics, University of Arkansas for Medical Sciences, 4301 West Markham, Slot 512-B, Little Rock, AR 72205, USA

Received 1 September 2010; Accepted 19 May 2011

Academic Editor: Anne Bartu

Copyright © 2011 Karen J. Farst et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. United States Department of Health and Human Services, “Results of the 2008 national survey on drug use and health,” 2009, http://www.oas.samhsa.gov/NSDUH/2k8NSDUH/2k8results.cfm#Ch2.
  2. B. M. Lester, M. ElSohly, L. L. Wright et al., “The maternal lifestyle study: drug use by meconium toxicology and maternal self-report,” Pediatrics, vol. 107, no. 2, pp. 309–317, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. E. M. Ostrea, M. Brady, S. Gause, A. L. Raymundo, and M. Stevens, “Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study,” Pediatrics, vol. 89, no. 1, pp. 107–113, 1992. View at Google Scholar · View at Scopus
  4. American Academy of Pediatrics, Committee on Substance Abuse, “Drug-exposed infants,” Pediatrics, vol. 96, no. 2, pp. 364–367, 1995. View at Google Scholar
  5. C. R. Bauer, “Perinatal effects of prenatal drug exposure,” Clinics in Perinatology, vol. 26, no. 1, pp. 87–106, 1999. View at Google Scholar · View at Scopus
  6. N. K. Young, S. Gardner, C. Otero et al., “Substance-exposed infants: state responses to the problem,” Tech. Rep. No. (SMA) 09-4369, Substance Abuse and Mental Health Services Administration, Rockville, Md, USA, 2009, http://www.ncsacw.samhsa.gov/files/Substance-Exposed-Infants.pdf.
  7. C. R. Bauer, S. Shankaran, H. S. Bada et al., “The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes,” American Journal of Obstetrics and Gynecology, vol. 186, no. 3, pp. 487–495, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Huestis and R. Choo, “Drug abuse's smallest victims: in utero drug exposure,” Forensic Science International, vol. 128, no. 1-2, pp. 20–30, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. K. M. Kuczkowski, “The effects of drug abuse on pregnancy,” Current Opinion in Obstetrics and Gynecology, vol. 19, no. 6, pp. 578–585, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. C. R. Bauer, J. C. Langer, S. Shankaran et al., “Acute neonatal effects of cocaine exposure during pregnancy,” Archives of Pediatrics and Adolescent Medicine, vol. 159, no. 9, pp. 824–834, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. L. M. Smith, L. L. LaGasse, C. Derauf et al., “The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth,” Pediatrics, vol. 118, no. 3, pp. 1149–1156, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Nguyen, L. M. Smith, L. L. LaGasse et al., “Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study,” Journal of Pediatrics, vol. 157, no. 2, pp. 337–339, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. B. L. Tabor, T. Smith-Wallace, and M. L. Yonekura, “Perinatal outcome associated with PCP versus cocaine use,” American Journal of Drug and Alcohol Abuse, vol. 16, no. 3-4, pp. 337–348, 1990. View at Google Scholar · View at Scopus
  14. L. M. Smith, L. L. LaGasse, C. Derauf et al., “Prenatal methamphetamine use and neonatal neurobehavioral outcome,” Neurotoxicology and Teratology, vol. 30, no. 1, pp. 20–28, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Wells, “Substance abuse and child maltreatment,” Pediatric Clinics of North America, vol. 56, no. 2, pp. 345–362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. C. Cloak, T. Ernst, L. Fujii, B. Hedemark, and L. Chang, “Lower diffusion in white matter of children with prenatal methamphetamine exposure,” Neurology, vol. 72, no. 24, pp. 2068–2075, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Kilic, C. Büyükünal, S. Dervisoglu, T. Y. Erdil, and E. Altiok, “Maternal cocaine abuse resulting in necrotizing enterocolitis. An experimental study in a rat model,” Pediatric Surgery International, vol. 16, no. 3, pp. 176–178, 2000. View at Google Scholar · View at Scopus
  18. United States Department of Health and Human Services, NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines, NIH Publication, July 2005, No. 05-4474.
  19. C. Y. Covington, B. Nordstrom-Klee, J. Ager, R. Sokol, and V. Delaney-Black, “Birth to age 7 growth of children prenatally exposed to drugs: a prospective cohort study,” Neurotoxicology and Teratology, vol. 24, no. 4, pp. 489–496, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. G. A. Richardson, L. Goldschmidt, and C. Larkby, “Effects of prenatal cocaine exposure on growth: a longitudinal analysis,” Pediatrics, vol. 120, no. 4, pp. e1017–e1027, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. L. T. Singer, S. Minnes, E. Short et al., “Cognitive outcomes of preschool children with prenatal cocaine exposure,” Journal of the American Medical Association, vol. 291, no. 20, pp. 2448–2456, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. E. S. Bandstra, A. L. Vogel, C. E. Morrow, L. Xue, and J. C. Anthony, “Severity of prenatal cocaine exposure and child language functioning through age seven years: a longitudinal latent growth curve analysis,” Substance Use and Misuse, vol. 39, no. 1, pp. 25–59, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Delaney-Black, C. Covington, T. Templin et al., “Teacher-assessed behavior of children prenatally exposed to cocaine,” Pediatrics, vol. 106, no. 4 I, pp. 782–791, 2000. View at Google Scholar · View at Scopus
  24. J. P. Ackerman, T. Riggins, and M. Black, “A review of the effects of prenatal cocaine exposure among school-aged children,” Pediatrics, vol. 125, no. 3, pp. 554–565, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Beeghly, B. Martin, R. Rose-Jacobs et al., “Prenatal cocaine exposure and children's language functioning at 6 and 9.5 years: moderating effects of child age, birthweight, and gender,” Journal of Pediatric Psychology, vol. 31, no. 1, pp. 98–115, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Eriksson, B. Jonsson, G. Steneroth, and R. Zetterstrãm, “Amphetamine abuse during pregnancy: environmental factors and outcome after 14–15 years,” Scandinavian Journal of Public Health, vol. 28, no. 2, pp. 154–157, 2000. View at Google Scholar · View at Scopus
  27. B. M. Lester and L. L. Lagasse, “Children of addicted women,” Journal of Addictive Diseases, vol. 29, no. 2, pp. 259–276, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. D. A. Osborne, H. E. Jeffrey, and M. J. Cole, “Opiate treatment for opiate withdrawal in newborn infants,” The Cochrane Collaboration, 2009. View at Google Scholar
  29. D. R. English, G. K. Hulse, E. Milne, C. D. Holman, and C. I. Bower, “Maternal cannabis use and birth weight: a meta-analysis,” Addiction, vol. 92, no. 11, pp. 1553–1560, 1997. View at Google Scholar · View at Scopus
  30. P. A. Fried and A. M. Smith, “A literature review of the consequences of prenatal marihuana exposure,” Neurotoxicology and Teratology, vol. 23, no. 1, pp. 1–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. M. R. Skelton, M. T. Williams, and C. V. Vorhees, “Developmental effects of 3,4-methylenedioxymethamphetamine: a review,” Behavioural Pharmacology, vol. 19, no. 2, pp. 91–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. B. N. Wikner, C. O. Stiller, U. Bergman, C. Asker, and B. Källén, “Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations,” Pharmacoepidemiology and Drug Safety, vol. 16, no. 11, pp. 1203–1210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. P. R. McElhatton, “The effects of benzodiazepine use during pregnancy and lactation,” Reproductive Toxicology, vol. 8, no. 6, pp. 461–475, 1994. View at Google Scholar · View at Scopus
  34. United States Drug Enforcement Administration, “Drug information resources,” 2002, http://www.usdoj.gov/dea/concern/concern.htm.
  35. D. L. Haller and D. R. Miles, “Victimization and perpetration among perinatal substance abusers,” Journal of Interpersonal Violence, vol. 18, no. 7, pp. 760–780, 2003. View at Google Scholar · View at Scopus
  36. J. B. Cohen, A. Dickow, K. Horner et al., “Abuse and violence history of men and women in treatment for methamphetamine dependence,” American Journal on Addictions, vol. 12, no. 5, pp. 377–385, 2003. View at Google Scholar · View at Scopus
  37. S. L. Hans, “Demographic and psychosocial characteristics of substance-abusing pregnant women,” Clinics in Perinatology, vol. 26, no. 1, pp. 55–74, 1999. View at Google Scholar · View at Scopus
  38. A. D. Kalechstein, T. F. Newton, D. Longshore, M. D. Anglin, W. G. Van Gorp, and F. H. Gawin, “Psychiatric comorbidity of methamphetamine dependence in a forensic sample,” Journal of Neuropsychiatry and Clinical Neurosciences, vol. 12, no. 4, pp. 480–484, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. S. R. Dube, R. F. Anda, V. J. Felitti, V. J. Edwards, and D. F. Williamson, “Exposure to abuse, neglect, and household dysfunction among adults who witnessed intimate partner violence as children: implications for health and social services,” Violence and Victims, vol. 17, no. 1, pp. 3–17, 2002. View at Google Scholar · View at Scopus
  40. T. M. Hogan, B. J. Myers, and R. K. Elswick, “Child abuse potential among mothers of substance-exposed and nonexposed infants and toddlers,” Child Abuse and Neglect, vol. 30, no. 2, pp. 145–156, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. J. M. Leventhal, B. W. Forsyth, K. Qi, L. Johnson, D. Schroeder, and N. Votto, “Maltreatment of children born to women who used cocaine during pregnancy: a population-based study,” Pediatrics, vol. 100, no. 1, p. e7, 1997. View at Google Scholar · View at Scopus
  42. R. E. Arendt, E. J. Short, L. T. Singer et al., “Children prenatally exposed to cocaine: development outcomes and environmental risks at seven years of age,” Journal of Developmental and Behavioral Pediatrics, vol. 25, no. 2, pp. 83–90, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. United States Department of Health and Human Services, “Child Abuse Prevention and Treatment Act,” 2010, http://www.acf.hhs.gov/programs/cb/laws_policies/cblaws/capta/.
  44. T. C. Kwong and R. M. Ryan, “Detection of intrauterine illicit drug exposure by newborn drug testing,” Clinical Chemistry, vol. 43, no. 1, pp. 235–242, 1997. View at Google Scholar · View at Scopus
  45. R. Oral and T. Strang, “Neonatal illicit drug screening practices in Iowa: the impact of utilization of a structured screening protocol,” Journal of Perinatology, vol. 26, no. 11, pp. 660–666, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. K. J. Farst, “Newborns exposed to illicit drugs in-utero,” Antenatal and Neonatal Guidelines, Education and Learning System, University of Arkansas for Medical Sciences, 2009, http://www.uams.edu/ANGELS/.
  47. Supreme Court of the United States (532 U.S. 67 2001), “Crystal M. Ferguson v City of Charleston S.C.,” 2001, http://www.law.cornell.edu/supct/html/99-936.ZS.html.
  48. J. L. Mitchell, Pregnant, Substance-Using Women Treatment Improvement Protocol (TIP) Series 2, U.S.Department of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, Rockville, Md, USA, 1995.
  49. J. L. Valentine and E. M. Komoroski, “Use of a visual panel detection method for drugs of abuse: clinical and laboratory experience with children and adolescents,” Journal of Pediatrics, vol. 126, no. 1, pp. 135–140, 1995. View at Publisher · View at Google Scholar · View at Scopus
  50. A. D. Woolf and M. W. Shannon, “Clinical toxicology for the pediatrician,” Pediatric Clinics of North America, vol. 42, no. 2, pp. 317–333, 1995. View at Google Scholar · View at Scopus
  51. K. W. Bibb, D. L. Stewart, J. R. Walker, V. D. Cook, and R. E. Wagener, “Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews,” Journal of Perinatology, vol. 15, no. 3, pp. 199–202, 1995. View at Google Scholar · View at Scopus
  52. J. Lozano, O. García-Algar, O. Vall, R. de la Torre, G. Scaravelli, and S. Pichini, “Biological matrices for the evaluation of in utero exposure to drugs of abuse,” Therapeutic Drug Monitoring, vol. 29, no. 6, pp. 711–734, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Gareri, J. Klein, and G. Koren, “Drugs of abuse testing in meconium,” Clinica Chimica Acta, vol. 366, no. 1-2, pp. 101–111, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Garcia-Bournissen, T. Karaskov, and G. Koren, “Methamphetamine detection in maternal and neonatal hair: implications for fetal safety,” Archives of Disease in Childhood. Fetal and Neonatal Edition, vol. 92, no. 5, pp. F351–F355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Montgomery, C. Plate, S. C. Alder, M. Jones, J. Jones, and R. D. Christensen, “Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium,” Journal of Perinatology, vol. 26, no. 1, pp. 11–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. E. J. Cone, D. Yousefnejad, M. J. Hillsgrove, B. Holicky, and W. D. Darwin, “Passive inhalation of cocaine,” Journal of Analytical Toxicology, vol. 19, no. 6, pp. 399–411, 1995. View at Google Scholar · View at Scopus
  57. K. Eskridge and S. K. Guthrie, “Clinical issues associated with urine testing of substances of abuse,” Pharmacotherapy, vol. 17, no. 3, pp. 497–510, 1997. View at Google Scholar · View at Scopus
  58. E. A. Kolbrich, A. J. Barnes, D. A. Gorelick, S. J. Boyd, E. J. Cone, and M. A. Huestis, “Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration,” Journal of Analytical Toxicology, vol. 30, no. 8, pp. 501–510, 2006. View at Google Scholar · View at Scopus
  59. H. S. Smith, “Opioid metabolism,” Mayo Clinic Proceedings, vol. 84, no. 7, pp. 613–624, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. American Academy of Pediatrics Committee on Fetus and Newborn, “Hospital discharge of the high-risk neonate—proposed guidelines,” Pediatrics, vol. 102, no. 2, pp. 411–417, 1998. View at Publisher · View at Google Scholar
  61. S. J. Kelley, “Parenting stress and child maltreatment in drug-exposed children,” Child Abuse and Neglect, vol. 16, no. 3, pp. 317–328, 1992. View at Publisher · View at Google Scholar · View at Scopus
  62. D. A. Frank, R. R. Jacobs, M. Beeghly et al., “Level of prenatal cocaine exposure and scores on the bayley scales of infant development: modifying effects of caregiver, early intervention, and birth weight,” Pediatrics, vol. 110, no. 6, pp. 1143–1152, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. D. L. Olds, L. Sadler, and H. Kitzman, “Programs for parents of infants and toddlers: recent evidence from randomized trials,” Journal of Child Psychology and Psychiatry and Allied Disciplines, vol. 48, no. 3-4, pp. 355–391, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. S. D. Krugman, W. G. Lane, and C. M. Walsh, “Update on child abuse prevention,” Current Opinion in Pediatrics, vol. 19, no. 6, pp. 711–718, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. A. M. Butz, M. Pulsifer, N. Marano, H. Belcher, M. K. Lears, and R. Royall, “Effectiveness of a home intervention for perceived child behavioral problems and parenting stress in children with in utero drug exposure,” Archives of Pediatrics and Adolescent Medicine, vol. 155, no. 9, pp. 1029–1037, 2001. View at Google Scholar · View at Scopus